Compose a new way to ask the same question. The new question must be asking the exact same thing as the original question does. Without any other information, you should be able to tell that the original question and the new question are the same. Preserve bracketed phrases in your new question. You can change the rest of the question provided the above requirements are satisfied. The new question must have a natural, fluent formulation, as if it were composed by a native English speaker. You will be given three pieces of information to help you create better questions. Those are: "Answer": the answer to the question, e.g., "Honolulu". "Answer Type": the type of the answer, e.g., "Location". "Auxiliary Information" is a detailed description of some concepts mentioned in the question, if any.

original question: Which type of fictional setting has [Chaeronea]?
answer: ancient warfare, classical antiquity
answer type: Type of fictional setting.
auxiliary information: Chaeronea is a village and a former municipality in Boeotia, Greece, located about 80 kilometers east of Delphi. Since the 2011 local government reform it is part of the municipality Livadeia, of which it is a municipal unit. Population 2,218. It is located by the mountain Thourion and in the Kifis√≥s river valley, NW of Thebes.
[Chaeronea] is taken place in what type of fictional setting?

original question: Which river is in [Cochem]?
answer: moselle
answer type: River.
auxiliary information: Cochem is the seat of and the biggest town in the Cochem-Zell district in Rhineland-Palatinate, Germany. With just under 5,000 inhabitants, Cochem falls just behind Kusel, in the like-named district, as Germany's second smallest district seat. Since 7 June 2009, it has belonged to the Verbandsgemeinde of Cochem.
What river runs through the German city of [Cochem]?

original question: What medical trial with expected total enrollment lower than [15] is funded by the sponsor of [A Multi-Center Clinical Trial to Evaluate Azidothymidine (AZT) in the Treatment of Human Immunodeficiency Virus (HIV) Infection in Patients with AIDS Post First Episode PCP]?
answer: a phase i evaluation of azidothymidine (azt) in children with acquired immune deficiency syndrome (aids) or aids related complex (arc)
answer type: Medical trial.
auxiliary information: To examine the dose of zidovudine (AZT) that was used in the first placebo-controlled study of AZT in AIDS patients as well as a lower dose of AZT in order to determine if the lower dose results in less harmful side effects while still being effective. Previous studies have shown the effectiveness of AZT in AIDS therapy. AZT has been effective in test tube studies at varying doses. There is a need to see if lower doses result in effective therapy with less harmful side effects.Previous studies have shown the effectiveness of AZT in AIDS therapy. AZT has been effective in test tube studies at varying doses. There is a need to see if lower doses result in effective therapy with less harmful side effects. Patients are assigned at random to one of two treatment programs: (1) 1 dose of AZT given orally (PO) for 6 doses per day; (2) 2 doses of AZT PO for 4 weeks followed by 1 dose PO for the remainder of the trial.

The sponsor of [A Multi-Center Clinical Trial to Evaluate Azidothymidine (AZT) in the Treatment of Human Immunodeficiency Virus (HIV) Infection in Patients with AIDS Post First Episode PCP] funded which medical trial with expected total enrollment lower than [15]?